Hasil Pencarian - Jonas S. Heitmann

Perbaiki Hasil
  1. 1
    Long-Term Follow-Up of COVID-19 Convalescents—Immune Response Associated with Reinfection Rate and Symptoms

    Long-Term Follow-Up of COVID-19 Convalescents—Immune Response Associated with Reinfection Rate and Symptoms oleh Anna Seller, Christopher Hackenbruch, Juliane S. Walz, Annika Nelde, Jonas S. Heitmann

    Diterbitkan 2023-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Expression of the immune checkpoint modulator OX40 indicates poor survival in acute myeloid leukemia

    Expression of the immune checkpoint modulator OX40 indicates poor survival in acute myeloid leukemia oleh Maddalena Marconato, Joseph Kauer, Helmut R. Salih, Melanie Märklin, Jonas S. Heitmann

    Diterbitkan 2022-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal cancer (CoRe_CC-3)

    Protocol of a first-in-human clinical trial to evaluate the safety, tolerability, and preliminary efficacy of the bispecific CD276xCD3 antibody CC-3 in patients with colorectal can... oleh Susanne Jung, Susanne Jung, Susanne Jung, Richard F. Schlenk, Richard F. Schlenk, Christopher Hackenbruch, Christopher Hackenbruch, Christopher Hackenbruch, Sandra S.L. Roldan Pinzon, Michael Bitzer, Martin Pflügler, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz, Gundram Jung, Jonas S. Heitmann, Jonas S. Heitmann, Jonas S. Heitmann, Helmut R. Salih, Helmut R. Salih

    Diterbitkan 2024-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    DNAM-1/CD226 is functionally expressed on acute myeloid leukemia (AML) cells and is associated with favorable prognosis

    DNAM-1/CD226 is functionally expressed on acute myeloid leukemia (AML) cells and is associated with favorable prognosis oleh Anna Chashchina, Melanie Märklin, Clemens Hinterleitner, Helmut R. Salih, Jonas S. Heitmann, Boris Klimovich

    Diterbitkan 2021-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome

    Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome oleh Christopher Hackenbruch, Yacine Maringer, Christian M. Tegeler, Juliane S. Walz, Annika Nelde, Jonas S. Heitmann

    Diterbitkan 2023-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Genetic Loss of LCK Kinase Leads to Acceleration of Chronic Lymphocytic Leukemia

    Genetic Loss of LCK Kinase Leads to Acceleration of Chronic Lymphocytic Leukemia oleh Melanie Märklin, Melanie Märklin, Alexander R. Fuchs, Claudia Tandler, Jonas S. Heitmann, Jonas S. Heitmann, Helmut R. Salih, Joseph Kauer, Leticia Quintanilla-Martinez, Stefan Wirths, Hans-Georg Kopp, Hans-Georg Kopp, Martin R. Müller, Martin R. Müller

    Diterbitkan 2020-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort

    Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort oleh Christian M. Tegeler, Tatjana Bilich, Yacine Maringer, Helmut R. Salih, Juliane S. Walz, Annika Nelde, Jonas S. Heitmann

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Protocol of a prospective, multicentre phase I study to evaluate the safety, tolerability and preliminary efficacy of the bispecific PSMAxCD3 antibody CC-1 in patients with castration-resistant prostate carcinoma

    Protocol of a prospective, multicentre phase I study to evaluate the safety, tolerability and preliminary efficacy of the bispecific PSMAxCD3 antibody CC-1 in patients with castrat... oleh Gundram Jung, Jonas S Heitmann, Juliane S Walz, Martin Pflügler, Joseph Kauer, Richard F Schlenk, Helmut R Salih

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    965 NFAT2 drives the cytoskeletal remodeling of leukemia cells, which regulates their vulnerability to perforin-mediated killing

    965 NFAT2 drives the cytoskeletal remodeling of leukemia cells, which regulates their vulnerability to perforin-mediated killing oleh Melanie Märklin, Jonas S Heitmann, Helmut R Salih, Samuel Holzmayer, Jonas Mauermann, Sarah Maria Greiner, Kuebra Kaban

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    1459 Association with stemness and functional role of immunoreceptor NKG2D expression in acute myeloid leukemia

    1459 Association with stemness and functional role of immunoreceptor NKG2D expression in acute myeloid leukemia oleh Ilona Hagelstein, Kathrin Rothfelder, Jonas S Heitmann, Helmut R Salih, Sylwia A Stefanczyk, Kim L Clar, Jonas Rieth

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimens

    iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimens oleh Alexander Englisch, Alexander Englisch, Alexander Englisch, Clara Hayn, Clara Hayn, Susanne Jung, Susanne Jung, Susanne Jung, Jonas S. Heitmann, Jonas S. Heitmann, Jonas S. Heitmann, Christopher Hackenbruch, Christopher Hackenbruch, Christopher Hackenbruch, Yacine Maringer, Yacine Maringer, Annika Nelde, Annika Nelde, Marcel Wacker, Marcel Wacker, Monika Denk, Lisa Zieschang, Christine Kammer, Peter Martus, Helmut R. Salih, Helmut R. Salih, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    1390 A Fc-optimized B7-H3 antibody for induction of NK cell reactivity against acute myeloid leukemia

    1390 A Fc-optimized B7-H3 antibody for induction of NK cell reactivity against acute myeloid leukemia oleh Melanie Märklin, Ilona Hagelstein, Jonas S Heitmann, Helmut R Salih, Latifa Zekri, Martina S Lutz, Sylwia A Stefanczyk, Stefanie Müller

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    IgG-based B7-H3xCD3 bispecific antibody for treatment of pancreatic, hepatic and gastric cancer

    IgG-based B7-H3xCD3 bispecific antibody for treatment of pancreatic, hepatic and gastric cancer oleh Martina S. Lutz, Martina S. Lutz, Latifa Zekri, Latifa Zekri, Latifa Zekri, Laura Weßling, Laura Weßling, Susanne Berchtold, Susanne Berchtold, Susanne Berchtold, Jonas S. Heitmann, Jonas S. Heitmann, Ulrich M. Lauer, Ulrich M. Lauer, Ulrich M. Lauer, Gundram Jung, Gundram Jung, Helmut R. Salih, Helmut R. Salih

    Diterbitkan 2023-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL)

    Immunoprofiling of 4-1BB Expression Predicts Outcome in Chronic Lymphocytic Leukemia (CLL) oleh Kübra Kaban, Sarah M. Greiner, Samuel Holzmayer, Claudia Tandler, Sophie Meyer, Clemens Hinterleitner, Helmut R. Salih, Melanie Märklin, Jonas S. Heitmann

    Diterbitkan 2021-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    Platelets subvert antitumor efficacy of T cell-recruiting bispecific antibodies

    Platelets subvert antitumor efficacy of T cell-recruiting bispecific antibodies oleh Melanie Märklin, Gundram Jung, Jonas S Heitmann, Helmut R Salih, Martina Svenja Lutz, Boris Klimovich, Stefanie Maurer, Latifa Zekri, Clemens Hinterleitner

    Diterbitkan 2022-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patients

    AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell an... oleh Susanne Jung, Susanne Jung, Susanne Jung, Annika Nelde, Annika Nelde, Yacine Maringer, Yacine Maringer, Monika Denk, Monika Denk, Monika Denk, Lisa Zieschang, Lisa Zieschang, Lisa Zieschang, Christine Kammer, Christine Kammer, Melek Özbek, Melek Özbek, Melek Özbek, Peter Martus, Christopher Hackenbruch, Christopher Hackenbruch, Christopher Hackenbruch, Alexander Englisch, Alexander Englisch, Alexander Englisch, Jonas S. Heitmann, Jonas S. Heitmann, Jonas S. Heitmann, Helmut R. Salih, Helmut R. Salih, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz, Juliane S. Walz

    Diterbitkan 2024-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    Regulation of Platelet-Derived ADAM17: A Biomarker Approach for Breast Cancer?

    Regulation of Platelet-Derived ADAM17: A Biomarker Approach for Breast Cancer? oleh Yanjun Zhou, Jonas S. Heitmann, Korbinian N. Kropp, Martina Hinterleitner, André Koch, Andreas D. Hartkopf, Helmut R. Salih, Clemens Hinterleitner, Stefanie Maurer

    Diterbitkan 2021-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer Progression

    Platelet-Expressed TNFRSF13B (TACI) Predicts Breast Cancer Progression oleh Clemens Hinterleitner, Clemens Hinterleitner, Yanjun Zhou, Yanjun Zhou, Claudia Tandler, Claudia Tandler, Jonas S. Heitmann, Jonas S. Heitmann, Korbinian N. Kropp, Martina Hinterleitner, Martina Hinterleitner, André Koch, Andreas D. Hartkopf, Lars Zender, Lars Zender, Lars Zender, Helmut R. Salih, Helmut R. Salih, Stefanie Maurer, Stefanie Maurer, Stefanie Maurer

    Diterbitkan 2021-03-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody

    Induction of NK cell reactivity against acute myeloid leukemia by Fc-optimized CD276 (B7-H3) antibody oleh Sylwia A. Stefańczyk, Ilona Hagelstein, Martina S. Lutz, Stefanie Müller, Samuel J. Holzmayer, Grace Jarjour, Latifa Zekri, Jonas S. Heitmann, Helmut R. Salih, Melanie Märklin

    Diterbitkan 2024-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas

    Bispecific NKG2D-CD3 and NKG2D-CD16 Fusion Proteins as Novel Treatment Option in Advanced Soft Tissue Sarcomas oleh Ilona Hagelstein, Ilona Hagelstein, Martina S. Lutz, Martina S. Lutz, Moritz Schmidt, Moritz Schmidt, Moritz Schmidt, Jonas S. Heitmann, Jonas S. Heitmann, Elke Malenke, Yanjun Zhou, Yanjun Zhou, Kim L. Clar, Kim L. Clar, Hans-Georg Kopp, Hans-Georg Kopp, Gundram Jung, Gundram Jung, Helmut R. Salih, Helmut R. Salih, Melanie Märklin, Melanie Märklin, Clemens Hinterleitner, Clemens Hinterleitner

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: